Bihar: First Cabinet Meet Vows To Give Free Covid-19 Vaccine To Everyone
The Nitish Kumar's Government declared to provide free Covid-19 vaccine in Bihar after the first cabinet meeting. "We feel Bihar’s biggest strength is its human resource and we want them to be protected against the deadly disease as the world is battling with the pandemic," Deputy CM Tarkishore Prasad said. The authorities has been assigned to work upon the delivery pattern of the vaccine and prioritise people based on their age and work… read-more
Tags: Covid-19, Corona Virus Vaccine, Nitish Kumar, health care, Free Covid-19 Vaccine
Courtesy: Hindustan Times
Efficacy Of Covaxin Can Be Learned Only After Second Dose
Clarifying about the efficacy of the Covid vaccine 'Covaxin', Bharat Biotech has said on December 5 that the success of the vaccine could only be determined after 14 days of the second dose. The explanation came after, Haryana Minister Anil Vij tested Covid positive despite taking the first shot of 'Covaxin' on November 20. The… read-more
Tags: Covaxin, Anil vij, National news, Corona Virus Vaccine
Courtesy: The Indian Express
India Eyes Key Partners For Vaccine Development, Distribution: Officials
The Indian officials informed that the government is looking for key partners to catalyze the development of the coronavirus vaccine. For this, a briefing event has been scheduled on November 6, wherein the government officials and Delhi-based diplomatic corps will discuss on the development of vaccine and exploring potential partners for its early and easy availability. The government has also prepared five models to facilitate co-operation… read-more
Tags: Covid-19, Corona Virus Vaccine, Indian government, Narendra Modi
Courtesy: Hindustan Times
Study Reveals COVID Antibodies Could Last For Over 5 Months
Amid COVID-19 reinfections, a study has asserted that the antibodies produced against the coronavirus are "relatively stable for at least five months". The study analysed over 30,000 patients and found that 90% participants produced strong antibody response to fight the virus and antibodies remained for "many months". The study used enzyme-linked immunosorbent assay (ELISA) to measure the antibodies. Experts opine that determining the… read-more
Tags: Covid-19, antibody, Corona Virus Vaccine, Study
Courtesy: The Economic Times
Union Health Minister Hints Of Late Stage Trials of Intranasal COVID-19 Vaccine in India
Speaking about the developments on COVID vaccines, Union Health Minister Dr Harshvardhan said the Serum Institute of India and Bharat Biotech may soon start late stage trials of an intranasal vaccine for COVID-19. However, he said the pharmaceutical companies are yet to receive regulatory approval and added that the late stage trials usually include over 30,000 participants. According to WHO, none of the intranasal vaccines for COVID-19 have… read-more
Tags: Corona Virus Vaccine, Covid-19, Bharat biotech, Serum Institute of India
Courtesy: The Times of India
Dr Reddy Gets DCGI Nod; Will Start Testing World's First COVID Vaccine In India
Dr Reddy on October 17 was granted permission by the Drug Controller General of India (DCGI) to conduct phase 2 and phase 3 trials of the first registered COVID vaccine, Sputnik in India. Dr Reddy has said that the controlled study will be multi-centred and randomized and "will include safety and immunogenicity study." Earlier, DCGI had rejected Dr Reddy's proposal of human trials as Russia had tested the vaccine on a small number of people… read-more
Tags: India, Corona Virus Vaccine, Russia, Sputnik-V
Courtesy: Hindustan Times